Safety, Pharmacokinetics and Efficacy of Dolutegravir in Treatment-experienced HIV-1 Infected Adolescents Forty-eight-week Results from IMPAACT P1093

Viani Rolando M.; Alvero Carmelita; Fenton Terry; Acosta Edward P.; Hazra Rohan; Townley Ellen; Steimers Debra; Min Sherene; Wiznia Andrew

首页> 外文期刊>The Pediatric infectious disease journal >Safety, Pharmacokinetics and Efficacy of Dolutegravir in Treatment-experienced HIV-1 Infected Adolescents Forty-eight-week Results from IMPAACT P1093

【24h】

Safety, Pharmacokinetics and Efficacy of Dolutegravir in Treatment-experienced HIV-1 Infected Adolescents Forty-eight-week Results from IMPAACT P1093

机译：Dolutegravir在经治疗经历的HIV-1感染青少年中的安全性，药代动力学和功效来自IMPAACT P1093的48周结果

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objective: To assess the pharmacokinetics (PK), safety and efficacy of dolutegravir plus optimized background regimen in HIV-infected treatment-experienced adolescents.

机译：目的：评估dolutegravir加上优化的背景方案在HIV感染治疗经验丰富的青少年中的药代动力学（PK），安全性和疗效。

著录项

来源
《The Pediatric infectious disease journal》 |2015年第11期|共7页
作者
Viani Rolando M.; Alvero Carmelita; Fenton Terry; Acosta Edward P.; Hazra Rohan; Townley Ellen; Steimers Debra; Min Sherene; Wiznia Andrew;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类儿科学;
关键词
antiretroviral agents; dolutegravir; HIV integrase inhibitors; pediatric HIV; adolescent HIV;

机译：抗逆转录病毒药物;多洛格韦;艾滋病毒整合酶抑制剂;小儿艾滋病毒;青少年艾滋病毒;

相似文献

外文文献
中文文献
专利

1. Safety, Pharmacokinetics and Efficacy of Dolutegravir in Treatment-experienced HIV-1 Infected Adolescents Forty-eight-week Results from IMPAACT P1093 [J] . Viani Rolando M., Alvero Carmelita, Fenton Terry, The Pediatric infectious disease journal . 2015,第11期

机译：Dolutegravir在经治疗经历的HIV-1感染青少年中的安全性，药代动力学和功效来自IMPAACT P1093的48周结果
2. Safety and Efficacy of Dolutegravir Plus Rilpivirine in Treatment-Experienced HIV-Infected Patients: The DORIVIR Study [J] . Rosario Palacios, M. Mayorga, C. M. González-Domenech, Journal of the International Association of Providers of AIDS Care. . 2018,第17期

机译：Dolutegravir和Rilpivirine在治疗经验丰富的HIV感染患者中的安全性和有效性：DORIVIR研究
3. Prevention of HIV-1 Transmission Through Breastfeeding: Efficacy and Safety of Maternal Antiretroviral Therapy Versus Infant Nevirapine Prophylaxis for Duration of Breastfeeding in HIV-1-Infected Women With High CD4 Cell Count (IMPAACT PROMISE): A Randomized, Open-Label, Clinical Trial [J] . Patricia M. Flynn, Taha E. Taha, Mae Cababasay, JAIDS: Journal of acquired immune deficiency syndromes . 2018,第4期

机译：通过母乳喂养预防HIV-1传播：母体抗逆转录病毒治疗的疗效和安全性与婴儿Nevirapine预防，HIV-1感染妇女的母乳喂养持续时间（IMPAACT承诺）：随机，开放标签，临床试验
4. Efficacy and Tolerance of TRIZIVIR in a Cohort of Naive Advanced HIV-1 Infected Adults [C] . H. Gallais, I. Ravaux, C. Tomei International AIDS Conference . 2004

机译：Trizivir在幼稚高级HIV-1感染成人队列中的疗效和耐受性
5. Pharmacokinetics and efficacy of oxytetracycline in WS-RLP-infected abalone. [D] . Rosenblum, Eric Sanford. 2006

机译：土霉素在WS-RLP感染的鲍鱼中的药代动力学和功效。
6. Safety Pharmacokinetics and Efficacy of Dolutegravir in Treatment-Experienced HIV-1 Infected Adolescents: 48-Week Results from IMPAACT P1093 [O] . Rolando M. Viani, Carmelita Alvero, Terry Fenton, -1

机译：在接受治疗的HIV-1感染青少年中多洛格韦的安全性药代动力学和功效：IMPAACT P1093的48周结果
7. Pharmacokinetics, Safety, and Efficacy of Maraviroc in Treatment-Experienced Pediatric Patients Infected With CCR5-Tropic HIV-1 [O] . Giaquinto, Carlo, Mawela, Muthuhadini Patience, Chokephaibulkit, Kulkanya, 2017

机译：Maraviroc在治疗经验丰富的CCR5-热带HIV-1感染小儿患者中的药代动力学，安全性和功效

Safety, Pharmacokinetics and Efficacy of Dolutegravir in Treatment-experienced HIV-1 Infected Adolescents Forty-eight-week Results from IMPAACT P1093

摘要

著录项

相似文献

相关主题

期刊订阅